Skip to content

Ameliorative effect of rufigallol on cisplatin-induced nephrotoxicity in rats: biochemical and histopathological evaluation.

Sep 2026 · Naunyn-Schmiedeberg's Archives of Pharmacology · 0 citations · 57 references
Medicine

TL;DR

Study results indicate that rufigallol may protect against cisplatin-induced nephrotoxicity; however, additional research is needed to confirm its effectiveness in humans.

View source

Similar papers

Open access Aug 2026

Protective Effects of Luteolin Against Cisplatin‐Induced Hepatic and Renal Toxicity: Biochemical and Cellular Evidence

It is suggested that Luteolin may represent a promising adjunctive candidate for reducing Cisplatin‐associated toxicity while improving therapeutic responsiveness and in vitro antiproliferative activity.

Ö. Temiz, Suna Kızılyıldırım, Tuba Ozdemir-Sanci et al. · 0 citations
Open access Aug 2026

Protective Effects of Nebivolol Against Cisplatin-Induced Nephrotoxicity: An Experimental Study

Nebivolol can ameliorate CIN in rats, as demonstrated by improvements in several renal functional, oxidative-stress, inflammatory, and histopathological outcomes, which support the nephroprotective potential of nebivolol but warrant confirmation in further preclinical studies.

Jamal J. Omer, D. Ibrahim, Mogahed A. Al-Shawia et al. · 0 citations
Open access Aug 2026

Assessment of Pinctada radiata extract effect in preventing cisplatin-induced kidney damage: biochemical, histopathological, and immunohistochemical evidence

Pinctada radiata lipid extract shows promising nephroprotective potential against cisplatin-induced toxicity, indicating renal protection via antioxidant, anti-apoptotic, and enhanced renal regeneration effects.

Nada S. Badr, Heba Abdelhamid Abdelkafar Shreif, Eman Radwan et al. · 0 citations
2026

Hesperidin attenuates cisplatin-induced cardiotoxicity in rats through regulating autophagy

Objective: Cisplatin is a well-known anticancer drug whose use has been limited due to a variety of side effects. Evidence has confirmed that cisplatin consumption is associated with cardiac toxicity. Unfortunately, no drug has yet been found to treat cardiac toxicity or reduce the side effects caused by cisplatin. How...

Hoori Heidari Kahkesh, Negin Amini, Mohammad Badavi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.